Article Versions Notes

Shibata K, Koibuchi N, Sanada F, Katsuragi N, Kanemoto Y, Tsunetoshi Y, Ikebe S, Yamamoto K, Morishita R, Shimazu K, et al. The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and Cancer. Cells. 2024; 13(17):1410. https://doi.org/10.3390/cells13171410

Shibata, Kana, Nobutaka Koibuchi, Fumihiro Sanada, Naruto Katsuragi, Yuko Kanemoto, Yasuo Tsunetoshi, Shoji Ikebe, Koichi Yamamoto, Ryuichi Morishita, Kenzo Shimazu, and et al. 2024. "The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and Cancer" Cells 13, no. 17: 1410. https://doi.org/10.3390/cells13171410

Shibata, K., Koibuchi, N., Sanada, F., Katsuragi, N., Kanemoto, Y., Tsunetoshi, Y., Ikebe, S., Yamamoto, K., Morishita, R., Shimazu, K., & Taniyama, Y. (2024). The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and Cancer. Cells, 13(17), 1410. https://doi.org/10.3390/cells13171410